SLAMF1 and colitis: In this T cell independent model of colitis, blockade of IFN-γ diminished LSK increases in the BM (Figure 6B) and spleen (Figure 6C), as well as CD34− LT-HSC and CD150+ LT-HSC increases in the BM (Figure 6B; data not shown).